Article Text

Download PDFPDF
Bone marrow mononuclear cell therapy for acute myocardial infarction: we know what we want, but we just don’t know how yet

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests KCW has filed a patent application covering the therapeutic use of bone marrow-derived proteins in cardiovascular disease.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles